Almost two decades ago the treatment of patients with inflammatory bowel disease (IBD) revolutionized with the introduction of anti-tumor necrosis factor (TNF) agents. However an ongoing debate is on the efficacy optimization of these...
14.01.2015 | Gastroenterologie